Table 2.
Factor | n | Odds ratio (95 % CI) | P value | Odds ratio (95 % CI) | P value | |
---|---|---|---|---|---|---|
Gln | With | 10 | 4.1 (0.6–33.7) | 0.17 | 4.0 (0.7–29.6) | 0.15 |
Without | 20 | |||||
Gln plus ED | With | 10 | 0.1 (0.0–0.7) | 0.03* | 0.1 (0.0–0.6) | 0.02* |
Without | 20 | |||||
Age, years | <70 | 16 | 3.1 (0.7–16.5) | 0.16 | 3.1 (0.7–16.1) | 0.15 |
≥70 | 14 | |||||
Sex | Male | 26 | 0.9 (0.1–7.7) | 0.95 | – | – |
Female | 4 | |||||
Cancer stage | IVa,b | 13 | 14.6 (1.9–150.0) | 0.01* | 13.3 (1.9–123.2) | 0.01* |
II–III | 17 | |||||
Treatment | First-line | 7 | 0.2 (0.0–2.1) | 0.19 | 0.2 (0.0–1.6) | 0.13 |
NAC | 23 | |||||
BMI | <21 | 13 | 1.9 (0.4–9.6) | 0.44 | – | – |
≥21 | 17 |
BMI body mass index, ED elemental diet, Gln glutamine, NAC neoadjuvant chemotherapy
*p < 0.05